Gabelli & Co Investment Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,250	Closed	-$240K	–	166
2017 Q4	$240K	Buy	+2,250	New	+$241K	0.03%	133
2017 Q1	–	Sell	-3,000	Closed	-$265K	–	160
2016 Q4	$265K	Buy	+3,000	New	+$273K	0.03%	123
2015 Q4	–	Sell	-3,000	Closed	-$303K	–	182
2015 Q3	$303K	Buy	+3,000	New	+$360K	0.04%	134
2014 Q2	–	Sell	-3,000	Closed	-$236K	–	143
2014 Q1	$236K	Buy	+3,000	New	+$250K	0.06%	101

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gabelli & Co Investment Advisers's IBB Position: Q1 2018 in Review

Gabelli & Co Investment Advisers sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 2,250 shares — an estimated $240K sold.

Gabelli & Co Investment Advisers first reported a position in IBB in Q1 2014 and held it in 4 quarters. The position peaked at $303K in Q3 2015. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

Gabelli & Co Investment Advisers reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 2,250 iShares Biotechnology ETF shares in Q1 2018, an estimated $240K.
Gabelli & Co Investment Advisers first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 4 quarters.
Gabelli & Co Investment Advisers's iShares Biotechnology ETF position peaked at $303K in Q3 2015.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2018, filed 9 May 2018.